Target intelligence / Profile preview

MIR4500 host gene (non-protein coding) (MIR4500HG)

Target
MIR4500HG
Molecular classification
Long non-coding RNA (lncRNA), miRNA host gene, Non-protein coding RNA
01

Overview

MIR4500 host gene (MIR4500HG) is a long non-coding RNA gene that contains the miRNA miR-4500 within its introns [1]. Its primary known biological role is to serve as the primary transcript (host) for miR-4500, a microRNA that acts as a tumor suppressor by inhibiting cell proliferation, migration, and invasion in a variety of cancers, including colorectal cancer [1]. miR-4500 achieves this by targeting oncogenes such as HMGA2, with MIR4500HG displaying promoter hypermethylation and silencing in tumors, leading to loss of miR-4500 function [1]. Like other lnc-pri-miRNA genes, MIR4500HG may also possess enhancer-like regulatory functions independent of its role as a miRNA host, though these non-canonical functions are suggested primarily through analogy with other similar lncRNA genes and are not yet specifically established for MIR4500HG [4]. MIR4500HG is a non-protein coding gene and is not considered an enzyme, receptor, or pharmacologic target molecule in the conventional sense. There are no recognized small molecules or drugs that interact directly with MIR4500HG, but its downregulation is being explored as a biomarker and potential diagnostic tool in oncology [1].

Other names
MIR4500 host gene (non-protein coding)hCG_1818123MIR4500HG
02

Mechanism of action

null (no drugs directly target this RNA gene; therapeutics could hypothetically aim to modulate miR-4500 expression)

03

Biological functions

miRNA precursor (host for miR-4500)Regulation of gene expression (via miRNA-dependent mechanisms)Regulation of cell proliferation, migration, and invasion (via miR-4500) [1]Potential enhancer-like (miRNA-independent) transcriptional regulation (inferred from related lnc-pri-miRNAs) [4]
04

Disease associations

Cancer (functions as tumor suppressor axis via miR-4500 in colorectal cancer and possibly other cancers) [1]Other (potential role in additional diseases, but evidence is limited to cancer contexts)
05

Safety considerations

no direct therapeutic agents or safety data for targeting this host gene; general challenges exist for lncRNA/miRNA-targeted therapies
06

Biomarkers

Downregulation of MIR4500/miR-4500 can serve as a prognostic or predictive biomarker in colorectal cancer and possibly other cancers [1]

Beyond the preview

Go deeper on MIR4500 host gene (non-protein coding) (MIR4500HG).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MIR4500 host gene (non-protein coding) (MIR4500HG).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call